Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1701-1710 of 2862 for cancer

Edit search filters
  1. Expanded Access Program To Provide Abemaciclib (LY2835219) For The Treatment Of Metastatic Breast Cancer

    Rochester, MN

  2. Combination Vaccine Immunotherapy (DRibbles) For Patients With Definitively-treated Stage III Non-small Cell Lung Cancer

    Scottsdale/Phoenix, AZ

  3. OTL38 For Intra-operative Imaging Of Folate Receptor Positive Ovarian Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  4. A Phase Ib Study Of Cobimetinib Administered In Combination With Niraparib, With Or Without Atezolizumab, To Patients With Advanced Platinum-Sensitive Ovarian Cancer

    Jacksonville, FL

  5. ASCENT-Study Of Sacituzumab Govitecan In Refractory/Relapsed Triple-Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  6. Letrozole In Treating Postmenopausal Women Who Have Received Hormone Therapy For Hormone Receptor-Positive Breast Cancer

    Eau Claire, WI

  7. Tucatinib, Trastuzumab, Ramucirumab, And Paclitaxel Versus Paclitaxel And Ramucirumab In Previously Treated HER2+ Gastroesophageal Cancer

    Scottsdale/Phoenix, AZ

  8. Hypofractionated Radiation Therapy Or Conventional Radiation Therapy After Surgery In Treating Patients With Prostate Cancer

    Albert Lea, MN, Eau Claire, WI, Jacksonville, FL, La Crosse, WI, Mankato, MN, Rochester, MN

  9. Lower Or Standard Dose Regorafenib In Treating Patients With Refractory Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  10. A Study To Evaluate HKI-272 And Capecitabine For HER2-Positive Breast Cancer And Brain Metastases

    Rochester, MN

.

Mayo Clinic Footer